The Icelandic founder mutation BRCA2 999del5: analysis of expression

INTRODUCTION: A founder mutation in the BRCA2 gene (BRCA2 999del5) accounts for 7–8% of female breast cancers and for 40% of male breast cancers in Iceland. If expressed, the mutant gene would encode a protein consisting of the first 256 amino acids of the BRCA2 protein. The purpose of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikaelsdottir, Evgenia K, Valgeirsdottir, Sigridur, Eyfjord, Jorunn E, Rafnar, Thorunn
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC468616/
https://www.ncbi.nlm.nih.gov/pubmed/15217494
http://dx.doi.org/10.1186/bcr785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC468616/
https://www.ncbi.nlm.nih.gov/pubmed/15217494
http://dx.doi.org/10.1186/bcr785

Ejemplares similares